HoneyLab

HoneyLab is a New Zealand-based pharmaceutical company that develops evidence-based health products derived from natural sources, specifically medical-grade Kanuka honey and bee venom. The company distinguishes itself by conducting rigorous clinical trials to validate the efficacy of its topical treatments for dermatological conditions such as rosacea, acne, and cold sores. Their flagship product, Honevo, is a patented formulation used in several skin health applications and is licensed to global partners like Taro Pharmaceuticals. HoneyLab also explores the therapeutic potential of bee venom for pain relief and anti-inflammatory purposes. The company's business model focuses on bridging the gap between traditional natural remedies and modern pharmaceutical standards through scientific validation.